Company’s land (additional disclosure) To: The President The Stock Exchange of Thailand The Board of directors meeting # 8/2019 held on June 4, 2019 has a resolution to sell a piece of land to increase
/2561 August 7, 2018 Subject: Management’s discussion and analysis of the Company’s operating results for Q2/2018 period To: President The Stock Exchange of Thailand DOD Biotech Public Company Limited
ที่ บช NO. AC. 004/2017 13 November 2017 Subject: Clarification of changes in operating performance of more than 20% To: The President of the Stock Exchange of Thailand M.K. Real Estate Development
million, increased by 120.46% QoQ. However, UWC recorded net loss of THB 17.64 million decreased by 94.24% QoQ. For the Year 2020, UWC recorded gross margin of THB 112.45 million, EBIT of THB 12.45 million
President The Stock Exchange of Thailand Rajthanee Hospital Public Company Limited (“the Company”) would like to clarify the operating results of the Company and its subsidiaries for the 2nd quarter of 2018
Justification_E_4-62 NO. AC. 01/2020 28 February 2020 Subject: Clarification of changes in operating performance of more than 20% To: The President of the Stock Exchange of Thailand M. K. Real Estate
Advertising revenue decreased by 45.0% YoY to THB 144mn. o System integration services revenue decreased by 14.2% YoY to THB 368mn. Recorded a share of loss from investment in joint ventures and associates of
Limited. The Company has already registered the changes to the Department of Business Development, Ministry of Commerce on April 17, 2019. In this regard, the Company still uses the same stock symbol “RATCH
MDA Q1_2018 (Eng.) May 7, 2018 Subject : Interim Management Discussion and Analysis of Q1/2018 Attention : President of The Stock Exchange of Thailand We attach herewith the financial statements of
Stock Exchange of Thailand The Company wishes to present the Management Discussion & Analysis (MD&A) on the operating and financial status for the year 2018. The MD&A would enable the investors to better